J Lawrence Marsh

"J Marsh"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu KY, Shyu YC, Barbaro BA, et al. (2015) Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease. Human Molecular Genetics. 24: 1602-16
Barbaro BA, Lukacsovich T, Agrawal N, et al. (2015) Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's disease. Human Molecular Genetics. 24: 913-25
Ochaba J, Lukacsovich T, Csikos G, et al. (2014) Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proceedings of the National Academy of Sciences of the United States of America. 111: 16889-94
Smith MR, Syed A, Lukacsovich T, et al. (2014) A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. Human Molecular Genetics. 23: 2995-3007
O'Rourke JG, Gareau JR, Ochaba J, et al. (2013) SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation. Cell Reports. 4: 362-75
Song W, Smith MR, Syed A, et al. (2013) Morphometric analysis of Huntington's disease neurodegeneration in Drosophila. Methods in Molecular Biology (Clifton, N.J.). 1017: 41-57
Sontag EM, Lotz GP, Agrawal N, et al. (2012) Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11109-19
Jia H, Pallos J, Jacques V, et al. (2012) Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease. Neurobiology of Disease. 46: 351-61
Bodai L, Marsh JL. (2012) A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 34: 142-8
Bodai L, Pallos J, Thompson LM, et al. (2012) Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's disease. Neuro-Degenerative Diseases. 9: 104-6
See more...